BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11566016)

  • 1. Alibra (VIVUS).
    Qureshi AA
    Curr Opin Investig Drugs; 2001 Apr; 2(4):550-4. PubMed ID: 11566016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
    Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
    J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
    Amar E
    Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
    Pangkahila WI
    Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 7. Topiglan MacroChem.
    McMahon CG
    Curr Opin Investig Drugs; 2002 Apr; 3(4):602-6. PubMed ID: 12090731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exisulind Cell Pathways.
    Griffiths GJ
    Curr Opin Investig Drugs; 2000 Nov; 1(3):386-91. PubMed ID: 11249724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction.
    Kongkanand A; Ratana-Olarn K; Wuddhikarn S; Luengwattanakit S; Tantiwong A; Ruengdilokrat S; Opanuraks J; Sripalakit S
    J Med Assoc Thai; 2002 Feb; 85(2):223-8. PubMed ID: 12081123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
    Raina R; Pahlajani G; Agarwal A; Zippe CD
    BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Porst H
    Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUSE therapy: preliminary clinical observations.
    Werthman P; Rajfer J
    Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bexarotene ligand pharmaceuticals.
    Hurst RE
    Curr Opin Investig Drugs; 2000 Dec; 1(4):514-23. PubMed ID: 11249708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transurethral alprostadil (MUSE) in erectile dysfunction].
    Comeri G; Gianneo E; Nespoli R
    Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the therapeutic approach of transurethral alprostadil.
    Ekman P; Sjögren L; Englund G; Persson BE
    BJU Int; 2000 Jul; 86(1):68-74. PubMed ID: 10886086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical conversations: intraurethral alprostadil (MUSE). Interview by Patricia Bates.
    Lewis J; Helfrick B; Marzucco J
    Urol Nurs; 1997 Dec; 17(4):159-61. PubMed ID: 9451246
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
    Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
    J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences].
    Porst H
    Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.